Moreover, the ovarian tumor domain allows the OTUD1 to separate IRF3 from the promoter region of the target gene and inhibits the normal production of interferon, while it does not affect the normal dimerization of IRF3 and translocate into the nucleus. The gene discussed is IRF3; the disease is ovarian neoplasm.